Anthrax Toxins

Bacillus anthracis and Anthrax

Volumn , Issue , 2010, Pages 121-156

  Moayeri, Mahtab ^a   Leppla, Stephen H ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Anthrax toxins; Macrophage function modulation of all of LT's immunomodulatory effects in macrophages and Mek cleavage and inhibition; Macrophage sensitivity role in lethal toxin (LT) and mediated death

Indexed keywords

EID: 80053315842     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470891193.ch8     Document Type: Chapter

References (262)

1. Abrami, L., Liu, S., Cosson, P., Leppla, S. H., and van der Goot, F. G. 2003. Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J Cell Biol, 160, 321 - 328.
2. Abrami, L., Lindsay, M., Parton, R. G., Leppla, S. H., and van der Goot, F. G. 2004. Membrane insertion of anthrax protective antigen and cytoplasmic delivery of lethal factor occur at different stages of the endocytic pathway. J Cell Biol, 166, 645 - 651.
3. Abrami, L., Leppla, S. H., and van der Goot, F. G. 2006. Receptor palmitoylation and ubiquitination regulate anthrax toxin endocytosis. J Cell Biol, 172, 309 - 320.
4. Abrami, L., Kunz, B., Deuquet, J., Bafi co, A., Davidson, G., and van der Goot, F. G. 2008. Functional interactions between anthrax toxin receptors and the WNT signaling protein LRP6. Cell Microbiol, 10, 2509 - 2519.
5. Agrawal, A., Lingappa, J., Leppla, S. H., Agrawal, S., Jabbar, A., Quinn, C. et al. 2003. Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin. Nature, 424, 329 - 334.
6. Alam, S., Gupta, M., and Bhatnagar, R. 2005. Inhibition of platelet aggregation by anthrax edema toxin. Biochem Biophys Res Commun, 339, 107 - 114.
7. Alfano, R. W., Leppla, S. H., Liu, S., Bugge, T. H., Duesbery, N. S., and Frankel, A. E. 2008. Potent inhibition of tumor angiogenesis by the matrix metalloproteinase-activated anthrax lethal toxin: implications for broad anti-tumor effi cacy. Cell Cycle, 7, 745 - 749.
8. Alileche, A., Serfass, E. R., Muehlbauer, S. M., Porcelli, S. A., and Brojatsch, J. 2005. Anthrax lethal toxin-mediated killing of human and murine dendritic cells impairs the adaptive immune response. PLoS Pathog, 1, e19.
9. Alileche, A., Squires, R. C., Muehlbauer, S. M., Lisanti, M. P., and Brojatsch, J. 2006. Mitochondrial impairment is a critical event in anthrax lethal toxin-induced cytolysis of murine macrophages. Cell Cycle, 5, 100 - 106.
10. Arora, N. and Leppla, S. H. 1993. Residues 1-254 of anthrax toxin lethal factor are suffi cient to cause cellular uptake of fused polypeptides. J Biol Chem, 268, 3334 - 3341.
11. Arora, N. and Leppla, S. H. 1994. Fusions of anthrax toxin lethal factor with shiga toxin and diphtheria toxin enzymatic domains are toxic to mammalian cells. Infect Immun, 62, 4955 - 4961.
12. Arora, N., Klimpel, K. R., Singh, Y., and Leppla, S. H. 1992. Fusions of anthrax toxin lethal factor to the ADP-ribosylation domain of Pseudomonas exotoxin A are potent cytotoxins which are translocated to the cytosol of mammalian cells. J Biol Chem, 267, 15542 - 15548.
13. Artenstein, A. W., Opal, S. M., Cristofaro, P., Palardy, J. E., Parejo, N. A., Green, M. D. et al. 2004. Chloroquine enhances survival in Bacillus anthracis intoxication. J Infect Dis, 190, 1655 - 1660.
14. Baldari, C. T., Tonello, F., Paccani, S. R., and Montecucco, C. 2006. Anthrax toxins: a paradigm of bacterial immune suppression. Trends Immunol, 27, 434 - 440.
15. Banks, D. J., Barnajian, M., Maldonado-Arocho, F. J., Sanchez, A. M., and Bradley, K. A. 2005. Anthrax toxin receptor 2 mediates Bacillus anthracis killing of macrophages following spore challenge. Cell Microbiol, 7, 1173 - 1185.
16. Bardwell, A. J., Flatauer, L. J., Matsukuma, K., Thorner, J., and Bardwell, L. 2001. A conserved docking site in MEKS mediates high-affi nity binding to map kinases and cooperates with a scaffold protein to enhance signal transmission. J Biol Chem, 276, 10374 - 10386.
17. Bardwell, A. J., Abdollahi, M., and Bardwell, L. 2003. Anthrax lethal factor-cleavage products of mitogen-activated protein kinase (MAPK) kinases exhibit reduced binding to their cognate MAPKs. Biochem J, 378, 569 - 577.
18. Barson, H. V., Mollenkopf, H., Kaufmann, S. H., and Rijpkema, S. 2008. Anthrax lethal toxin suppresses chemokine production in human neutrophil NB-4 cells. Biochem Biophys Res Commun, 374, 288 - 293.
19. Batty, S., Chow, E. M., Kassam, A., Der, S. D., and Mogridge, J. 2006. Inhibition of mitogen-activated protein kinase signalling by Bacillus anthracis lethal toxin causes destabilization of interleukin-8 mRNA. Cell Microbiol, 8, 130 - 138.
20. Beauregard, K. E., Collier, R. J., and Swanson, J. A. 2000. Proteolytic activation of receptor-bound anthrax protective antigen on macrophages promotes its internalization. Cell Microbiol, 2, 251 - 258.
21. Bell, S. E., Mavila, A., Salazar, R., Bayless, K. J., Kanagala, S., Maxwell, S. A. et al. 2001. Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling. J Cell Sci, 114, 2755 - 2773.
22. Bhatnagar, R., Singh, Y., Leppla, S. H., and Friedlander, A. M. 1989. Calcium is required for the expression of anthrax lethal toxin activity in the macrophagelike cell line J774A.1. Infect Immun, 57, 2107 - 2114.
23. Bhatnagar, R., Ahuja, N., Goila, R., Batra, S., Waheed, S. M., and Gupta, P. 1999. Activation of phospholipase C and protein kinase C is required for expression of anthrax lethal toxin cytotoxicity in J774A.1 cells. Cell Signal, 11, 111 - 116.
24. Bolcome, R. E., III, Sullivan, S. E., Zeller, R., Barker, A. P., Collier, R. J., and Chan, J. 2008. Anthrax lethal toxin induces cell death-independent permeability in zebrafi sh vasculature. Proc Natl Acad Sci U S A, 105, 2439 - 2444.
25. Boll, W., Ehrlich, M., Collier, R. J., and Kirchhausen, T. 2004. Effects of dynamin inactivation on pathways of anthrax toxin uptake. Eur J Cell Biol, 83, 281 - 288.
26. Bonuccelli, G., Sotgia, F., Frank, P. G., Williams, T. M., de Almeida, C. J., Tanowitz, H. B. et al. 2005. Anthrax toxin receptor (ATR/TEM8) is highly expressed in epithelial cells lining the toxin ' s three sites of entry (lung, skin, and intestine). Am J Physiol Cell Physiol, 288, C1402 - C1410.
27. Boyden, E. D. and Dietrich, W. F. 2006. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet, 38, 240 - 244.
28. Bradburne, C., Chung, M. C., Zong, Q., Schlauch, K., Liu, D., Popova, T. et al. 2008. Transcriptional and apoptotic responses of THP-1 cells to challenge with toxigenic, and non-toxigenic Bacillus anthracis. BMC Immunol, 9, 67.
29. Bradley, K. A., Mogridge, J., Mourez, M., Collier, R. J., and Young, J. A. 2001. Identifi cation of the cellular receptor for anthrax toxin. Nature, 414, 225 - 229.
30. Bradley, K. A., Mogridge, J., Rainey, G. J., Batty, S., and Young, J. A. 2003. Binding of anthrax toxin to its receptor is similar to alpha integrin-ligand interactions. J Biol Chem, 278, 49342 - 49347.
31. Buck, M. and Chojkier, M. 2007. C/EBPbeta phosphorylation rescues macrophage dysfunction and apoptosis induced by anthrax lethal toxin. Am J Physiol Cell Physiol, 293, C1788 - C1796.
32. Carson-Walter, E. B., Watkins, D. N., Nanda, A., Vogelstein, B., Kinzler, K. W., and, St. Croix, B. 2001. Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res, 61, 6649 - 6655.
33. Cataldi, A., Labruyere, E., and Mock, M. 1990. Construction and characterization of a protective antigen-defi cient Bacillus anthracis strain. Mol Microbiol, 4, 1111 - 1117.
34. Chandra, H., Gupta, P. K., Sharma, K., Mattoo, A. R., Garg, S. K., Gade, W. N. et al. 2005. Proteome analysis of mouse macrophages treated with anthrax lethal toxin. Biochim Biophys Acta, 1747, 151 - 159.
35. Chapelsky, S., Batty, S., Frost, M., and Mogridge, J. 2008. Inhibition of anthrax lethal toxin-induced cytolysis of RAW264.7 cells by celastrol. PLoS ONE, 3, e1421.
36. Chen, K. H., Liu, S., Bankston, L. A., Liddington, R. C., and Leppla, S. H. 2007. Selection of anthrax toxin protective antigen variants that discriminate between the cellular receptors TEM8 and CMG2 and achieve targeting of tumor cells. J Biol Chem, 282, 9834 - 9846.
37. Chopra, A. P., Boone, S. A., Liang, X., and Duesbery, N. S. 2003. Anthrax lethal factor proteolysis and inactivation of MAP-kinase-kinase. J Biol Chem, 278, 9402 - 9406.
38. Chou, P. J., Newton, C. A., Perkins, I., Friedman, H., and Klein, T. W. 2008. Suppression of dendritic cell activation by anthrax lethal toxin and edema toxin depends on multiple factors including cell source, stimulus used, and function tested. DNA Cell Biol, 27, 637 - 648.
39. Cleret, A., Quesnel-Hellmann, A., Mathieu, J., Vidal, D., and Tournier, J. N. 2006. Resident CD11c + lung cells are impaired by anthrax toxins after spore infection. J Infect Dis, 194, 86 - 94.
40. Comer, J. E., Chopra, A. K., Peterson, J. W., and Konig, R. 2005a. Direct inhibition of T-lymphocyte activation by anthrax toxins in vivo. Infect Immun, 73, 8275 - 8281.
41. Comer, J. E., Galindo, C. L., Chopra, A. K., and Peterson, J. W. 2005b. GeneChip analyses of global transcriptional responses of murine macrophages to the lethal toxin of Bacillus anthracis. Infect Immun, 73, 1879 - 1885.
42. Comer, J. E., Galindo, C. L., Zhang, F., Wenglikowski, A. M., Bush, K. L., Garner, H. R. et al. 2006. Murine macrophage transcriptional and functional responses to Bacillus anthracis edema toxin. Microb Pathog, 41, 96 - 110.
43. Cordoba-Rodriguez, R., Fang, H., Lankford, C. S., and Frucht, D. M. 2004. Anthrax lethal toxin rapidly activates caspase-1/ICE and induces extracellular release of interleukin (IL)-1beta and IL-18. J Biol Chem, 279, 20563 - 20566.
44. Cote, C. K., DiMezzo, T. L., Banks, D. J., France, B., Bradley, K. A., and Welkos, S. L. 2008. Early interactions between fully virulent Bacillus anthracis and macrophages that infl uence the balance between spore clearance and development of a lethal infection. Microbes Infect, 10, 613 - 619.
45. Crawford, M. A., Aylott, C. V., Bourdeau, R. W., and Bokoch, G. M. 2006. Bacillus anthracis toxins inhibit human neutrophil NADPH oxidase activity. J Immunol, 176, 7557 - 7565.
46. Cui, X., Moayeri, M., Li, Y., Li, X., Haley, M., Fitz, Y. et al. 2004. Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not infl ammatory cytokine or nitric oxide release in rats. Am J Physiol Regul Integr Comp Physiol, 286, R699 - R709.
47. Cui, X., Li, Y., Li, X., Haley, M., Moayeri, M., Fitz, Y. et al. 2006. Sublethal doses of Bacillus anthracis lethal toxin inhibit infl ammation with lipopolysaccharide and Escherichia coli challenge but have opposite effects on survival. J Infect Dis, 193, 829 - 840.
48. Cui, X., Li, Y., Li, X., Laird, M. W., Subramanian, M., Moayeri, M. et al. 2007. Bacillus anthracis edema and lethal toxin have different hemodynamic effects but function together to worsen shock and outcome in a rat model. J Infect Dis, 195, 572 - 580.
49. Cunningham, K., Lacy, D. B., Mogridge, J., and Collier, R. J. 2002. Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen. Proc Natl Acad Sci U S A, 99, 7049 - 7053.
50. Dadachova, E., Rivera, J., Revskaya, E., Nakouzi, A., Cahill, S. M., Blumenstein, M. et al. 2008. In vitro evaluation, biodistribution and scintigraphic imaging in mice of radiolabeled anthrax toxins. Nucl Med Biol, 35, 755 - 761.
51. Dal Molin, F., Tonello, F., Ladant, D., Zornetta, I., Zamparo, I., Benedetto, G. D. et al. 2006. Cell entry and cAMP imaging of anthrax edema toxin. EMBO J, 15, 5405 - 5413.
52. Dal Molin, F., Fasanella, A., Simonato, M., Garofolo, G., Montecucco, C., and Tonello, F. 2008. Ratio of lethal and edema factors in rabbit systemic anthrax. Toxicon, 52, 824 - 828.
53. DeCathelineau, A. M. and Bokoch, G. M. 2009. Inactivation of rho GTPases by statins attenuates anthrax lethal toxin activity. Infect Immun, 77, 348 - 359.
54. Depeille, P. E., Ding, Y., Bromberg-White, J. L., and Duesbery, N. S. 2007. MKK signaling and vascularization. Oncogene, 26, 1290 - 1296.
55. Deshpande, A., Hammon, R. J., Sanders, C. K., and Graves, S. W. 2006. Quantitative analysis of the effect of cell type and cellular differentiation on protective antigen binding to human target cells. FEBS Lett, 580, 4172 - 4175.
56. Deuquet, J., Abrami, L., Difeo, A., Ramirez, M. C., Martignetti, J. A., and van der Goot, F. G. 2009. Systemic hyalinosis mutations in the CMG2 ectodomain leading to loss of function through retention in the endoplasmic reticulum. Hum Mutat. Published online February 3, 2009.
57. Dixon, T. C., Fadl, A. A., Koehler, T. M., Swanson, J. A., and Hanna, P. C. 2000. Early Bacillus anthracis-macrophage interactions: intracellular survival and escape. Cell Microbiol, 2, 453 - 463.
58. Dowling, O., Difeo, A., Ramirez, M. C., Tukel, T., Narla, G., Bonafe, L. et al. 2003. Mutations in capillary morphogenesis gene-2 result in the allelic disorders juvenile hyaline fi bromatosis and infantile systemic hyalinosis. Am J Hum Genet, 73, 957 - 966.
59. Drum, C. L., Yan, S. Z., Sarac, R., Mabuchi, Y., Beckingham, K., Bohm, A. et al. 2000. An extended conformation of calmodulin induces interactions between the structural domains of adenylyl cyclase from Bacillus anthracis to promote catalysis. J Biol Chem, 275, 36334 - 36340.
60. Drum, C. L., Yan, S. Z., Bard, J., Shen, Y. Q., Lu, D., Soelaiman, S. et al. 2002. Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. Nature, 415, 396 - 402.
61. Drysdale, M., Olson, G., Koehler, T. M., Lipscomb, M. F., and Lyons, C. R. 2007. Murine innate immune response to virulent toxigenic and non-toxigenic Bacillus anthracis strains. Infect Immun, 75, 1757 - 1764.
62. Duesbery, N. S., Webb, C. P., Leppla, S. H., Gordon, V. M., Klimpel, K. R., Copeland, T. D. et al. 1998. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science, 280, 734 - 737.
63. Duesbery, N. S., Resau, J., Webb, C. P., Koochekpour, S., Koo, H. M., Leppla, S. H. et al. 2001. Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways. Proc Natl Acad Sci U S A, 98, 4089 - 4094.
64. During, R. L., Li, W., Hao, B., Koenig, J. M., Stephens, D. S., Quinn, C. P. et al. 2005. Anthrax lethal toxin paralyzes neutrophil actin-based motility. J Infect Dis, 192, 837 - 845.
65. During, R. L., Gibson, B. G., Li, W., Bishai, E. A., Sidhu, G. S., Landry, J. et al. 2007. Anthrax lethal toxin paralyzes actin-based motility by blocking Hsp27 phosphorylation. EMBO J, 26, 2240 - 2250.
66. Elliott, J. L., Mogridge, J., and Collier, R. J. 2000. A quantitative study of the interactions of Bacillus anthracis edema factor and lethal factor with activated protective antigen. Biochemistry, 39, 6706 - 6713.
67. Erwin, J. L., DaSilva, L. M., Bavari, S., Little, S. F., Friedlander, A. M., and Chanh, T. C. 2001. Macrophage-derived cell lines do not express proinfl ammatory cytokines after exposure to Bacillus anthracis lethal toxin. Infect Immun, 69, 1175 - 1177.
68. Escuyer, V. and Collier, R. J. 1991. Anthrax protective antigen interacts with a specifi c receptor on the surface of CHO-K1 cells. Infect Immun, 59, 3381 - 3386.
69. Ezzell, J. W., Ivins, B. E., and Leppla, S. H. 1984. Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin. Infect Immun, 45, 761 - 767.
70. Ezzell, J. W. Jr. and Abshire, T. G. 1992. Serum protease cleavage of Bacillus anthracis protective antigen. J Gen Microbiol, 138, 543 - 549.
71. Fang, H., Cordoba-Rodriguez, R., Lankford, C. S., and Frucht, D. M. 2005. Anthrax lethal toxin blocks MAPK kinase-dependent IL-2 production in CD4 + T cells. J Immunol, 174, 4966 - 4971.
72. Fang, H., Xu, L., Chen, T. Y., Cyr, J. M., and Frucht, D. M. 2006. Anthrax lethal toxin has direct and potent inhibitory effects on B cell proliferation and immunoglobulin production. J Immunol, 176, 6155 - 6161.
73. Fink, S. L., Bergsbaken, T., and Cookson, B. T. 2008. Anthrax lethal toxin and Salmonella elicit the common cell death pathway of caspase-1-dependent pyroptosis via distinct mechanisms. Proc Natl Acad Sci U S A, 105, 4312 - 4317.
74. Firoved, A. M., Miller, G. F., Moayeri, M., Kakkar, R., Shen, Y., Wiggins, J. F. et al. 2005. Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Am J Pathol, 167, 1309 - 1320.
75. Firoved, A. M., Moayeri, M., Wiggins, J. F., Shen, Y., Tang, W. J., and Leppla, S. H. 2007. Anthrax edema toxin sensitizes DBA/2J mice to lethal toxin. Infect Immun, 75, 2120 - 2125.
76. Friedlander, A. M. 1986. Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. J Biol Chem, 261, 7123 - 7126.
77. Friedlander, A. M., Bhatnagar, R., Leppla, S. H., Johnson, L., and Singh, Y. 1993. Characterization of macrophage sensitivity and resistance to anthrax lethal toxin. Infect Immun, 61, 245 - 252.
78. Fritz, D. L., Jaax, N. K., Lawrence, W. B., Davis, K. J., Pitt, M. L., Ezzell, J. W. et al. 1995. Pathology of experimental inhalation anthrax in the rhesus monkey. Lab Invest, 73, 691 - 702.
79. Gimenez, A. P., Wu, Y. Z., Paya, M., Delclaux, C., Touqui, L., and Goossens, P. L. 2004. High bactericidal effi ciency of type IIA phospholipase A(2) against Bacillus anthracis and inhibition of its secretion by the lethal toxin. J Immunol, 173, 521 - 530.
80. Go, M. Y., Kim, S., Partridge, A. W., Melnyk, R. A., Rath, A., Deber, C. M. et al. 2006. Self-association of the transmembrane domain of an anthrax toxin receptor. J Mol Biol, 360, 145 - 156.
81. Go, M. Y., Chow, E. M., and Mogridge, J. 2009. The cytoplasmic domain of anthrax toxin receptor 1 affects binding of the protective antigen. Infect Immun, 77, 52 - 59.
82. Gordon, V. M. and Leppla, S. H. 1994. Proteolytic activation of bacterial toxins: role of bacterial and host cell proteases. Infect Immun, 62, 333 - 340.
83. Gordon, V. M., Leppla, S. H., and Hewlett, E. L. 1988. Inhibitors of receptor-mediated endocytosis block the entry of Bacillus anthracis adenylate cyclase toxin but not that of Bordetella pertussis adenylate cyclase toxin. Infect Immun, 56, 1066 - 1069.
84. Gordon, V. M., Young, W. W. Jr. , Lechler, S. M., Gray, M. C., Leppla, S. H., and Hewlett, E. L. 1989. Adenylate cyclase toxins from Bacillus anthracis and Bordetella pertussis. Different processes for interaction with and entry into target cells. J Biol Chem, 264, 14792 - 14796.
85. Gordon, V. M., Klimpel, K. R., Arora, N., Henderson, M. A., and Leppla, S. H. 1995. Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases. Infect Immun, 63, 82 - 87.
86. Gozes, Y., Moayeri, M., Wiggins, J. F., and Leppla, S. H. 2006. Anthrax lethal toxin induces ketotifen-sensitive intradermal vascular leakage in certain inbred mice. Infect Immun, 74, 1266 - 1272.
87. Grinberg, L. M., Abramova, F. A., Yampolskaya, O. V., Walker, D. H., and Smith, J. H. 2001. Quantitative pathology of inhalational anthrax I: quantitative microscopic fi ndings. Mod Pathol, 14, 482 - 495.
88. Guidi-Rontani, C., Weber-Levy, M., Mock, M., and Cabiaux, V. 2000. Translocation of Bacillus anthracis lethal and oedema factors across endosome membranes. Cell Microbiol, 2, 259 - 264.
89. Guidi-Rontani, C., Levy, M., Ohayon, H., and Mock, M. 2001. Fate of germinated Bacillus anthracis spores in primary murine macrophages. Mol Microbiol, 42, 931 - 938.
90. Guo, Q., Jureller, J. E., Warren, J. T., Solomaha, E., Florian, J., and Tang, W. J. 2008. Protein-protein docking and analysis reveal that two homologous bacterial adenylyl cyclase toxins interact with calmodulin differently. J Biol Chem, 283, 23836 - 23845.
91. Gupta, M., Alam, S., and Bhatnagar, R. 2005. Kinetic characterization and ligand binding studies of His351 mutants of Bacillus anthracis adenylate cyclase. Arch Biochem Biophys, 446, 28 - 34.
92. Gupta, P. K., Moayeri, M., Crown, D., Fattah, R. J., and Leppla, S. H. 2008. Role of N-terminal amino acids in the potency of anthrax lethal factor. PLoS ONE, 3, e3130.
93. Ha, S. D., Ng, D., Lamothe, J., Valvano, M. A., Han, J., and Kim, S. O. 2007a. Mitochondrial proteins Bnip3 and Bnip3L are involved in anthrax lethal toxin-induced macrophage cell death. J Biol Chem, 282, 26275 - 26283.
94. Ha, S. D., Ng, D., Pelech, S. L., and Kim, S. O. 2007b. Critical role of PI3-K/Akt/GSK-3beta signaling pathway in recovery from anthrax lethal toxin-induced cell cycle arrest and MEK cleavage in macrophages. J Biol Chem, 282, 36230 - 36239.
95. Hammamieh, R., Ribot, W. J., Abshire, T. G., Jett, M., and Ezzell, J. 2008. Activity of the Bacillus anthracis kDa protective antigen component. BMC Infect Dis, 8, 124 - 129.
96. Hanks, S., Adams, S., Douglas, J., Arbour, L., Atherton, D. J., Balci, S. et al. 2003. Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyaline fi bromatosis and infantile systemic hyalinosis. Am J Hum Genet, 73, 791 - 800.
97. Hanna, P. C., Kochi, S., and Collier, R. J. 1992. Biochemical and physiological changes induced by anthrax lethal toxin in J774 macrophage-like cells. Mol Biol Cell, 3, 1269 - 1277.
98. Hanna, P. C., Acosta, D., and Collier, R. J. 1993. On the role of macrophages in anthrax. Proc Natl Acad Sci U S A, 90, 10198 - 10201.
99. Hanna, P. C., Kruskal, B. A., Ezekowitz, R. A., Bloom, B. R., and Collier, R. J. 1994. Role of macrophage oxidative burst in the action of anthrax lethal toxin. Mol Med, 1, 7 - 18.
100. Heninger, S., Drysdale, M., Lovchik, J., Hutt, J., Lipscomb, M. F., Koehler, T. M. et al. 2006. Toxin-defi cient mutants of Bacillus anthracis are lethal in a murine model for pulmonary anthrax. Infect Immun, 74, 6067 - 6074.
101. Hong, J., Beeler, J., Zhukovskaya, N. L., He, W., Tang, W. J., and Rosner, M. R. 2005. Anthrax edema factor potency depends on mode of cell entry. Biochem Biophys Res Commun, 335, 850 - 857.
102. Hong, J., Doebele, R. C., Lingen, M. W., Quilliam, L. A., Tang, W. J., and Rosner, M. R. 2007. Anthrax edema toxin inhibits endothelial cell chemotaxis via Epac and Rap1. J Biol Chem, 282, 19781 - 19787.
103. Hoover, D. L., Friedlander, A. M., Rogers, L. C., Yoon, I. K., Warren, R. L., and Cross, A. S. 1994. Anthrax edema toxin differentially regulates lipopolysaccharide-induced monocyte production of tumor necrosis factor alpha and interleukin-6 by increasing intracellular cyclic AMP. Infect Immun, 62, 4432 - 4439.
104. Hotchkiss, K. A., Basile, C. M., Spring, S. C., Bonuccelli, G., Lisanti, M. P., and Terman, B. I. 2005. TEM8 expression stimulates endothelial cell adhesion and migration by regulating cell-matrix interactions on collagen. Exp Cell Res, 305, 133 - 144.
105. Hsu, L. C., Ali, S. R., McGillivray, S., Tseng, P. H., Mariathasan, S., Humke, E. W. et al. 2008. A NOD2-NALP1 complex mediates caspase-1-dependent IL-1{beta} secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc Natl Acad Sci U S A, 105, 7803 - 7808.
106. Hu, H., Sa, Q., Koehler, T. M., Aronson, A. I., and Zhou, D. 2006. Inactivation of Bacillus anthracis spores in murine primary macrophages. Cell Microbiol, 8, 1634 - 1642.
107. Huang, D., Ding, Y., Luo, W. M., Bender, S., Qian, C. N., Kort, E. et al. 2008. Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo. Cancer Res, 68, 81 - 88.
108. Kassam, A., Der, S. D., and Mogridge, J. 2005. Differentiation of human monocytic cell lines confers susceptibility to Bacillus anthracis lethal toxin. Cell Microbiol, 7, 281 - 292.
109. Kau, J. H., Lin, C. G., Huang, H. H., Hsu, H. L., Chen, K. C., Wu, Y. P. et al. 2002. Calyculin A sensitive protein phosphatase is required for Bacillus anthracis lethal toxin induced cytotoxicity. Curr Microbiol, 44, 106 - 111.
110. Kau, J. H., Sun, D. S., Tsai, W. J., Shyu, H. F., Huang, H. H., Lin, H. C. et al. 2005. Antiplatelet activities of anthrax lethal toxin are associated with suppressed p42/44 and p38 mitogen-activated protein kinase pathways in the platelets. J Infect Dis, 192, 1465 - 1474.
111. Kim, C., Gajendran, N., Mittrucker, H. W., Weiwad, M., Song, Y. H., Hurwitz, R. et al. 2005. Human {alpha}-defensins neutralize anthrax lethal toxin and protect against its fatal consequences. Proc Natl Acad Sci U S A, 102, 4830 - 4835.
112. Kim, C., Wilcox-Adelman, S., Sano, Y., Tang, W. J., Collier, R. J., and Park, J. M. 2008. Anti-infl ammatory cAMP signaling and cell migration genes co-opted by the anthrax bacillus. Proc Natl Acad Sci U S A, 105, 6150 - 6155.
113. Kim, S. O., Jing, Q., Hoebe, K., Beutler, B., Duesbery, N. S., and Han, J. 2002. Sensitizing anthrax lethal toxin-resistant macrophages to lethal toxin-induced killing by tumor necrosis factor-alpha. J Biol Chem, 278, 7413 - 7421.
114. Kirby, J. E. 2004. Anthrax lethal toxin induces human endothelial cell apoptosis. Infect Immun, 72, 430 - 439.
115. Klimpel, K. R., Arora, N., and Leppla, S. H. 1994. Anthrax toxin lethal factor contains a zinc metalloprote ase consensus sequence which is required for lethal toxin activity. Mol Microbiol, 13, 1093 - 1100.
116. Kocer, S. S., Matic, M., Ingrassia, M., Walker, S. G., Roemer, E., Licul, G. et al. 2008. Effects of anthrax lethal toxin on human primary keratinocytes. J Appl Microbiol, 105, 1756 - 1767.
117. Koo, H. M., VanBrocklin, M., McWilliams, M. J., Leppla, S. H., Duesbery, N. S., and Woude, G. F. 2002. Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinase. Proc Natl Acad Sci U S A, 99, 3052 - 3057.
118. Krantz, B. A., Trivedi, A. D., Cunningham, K., Christensen, K. A., and Collier, R. J. 2004. Acid-induced unfolding of the amino-terminal domains of the lethal and edema factors of anthrax toxin. J Mol Biol, 344, 739 - 756.
119. Krantz, B. A., Finkelstein, A., and Collier, R. J. 2005. Protein translocation through the anthrax toxin transmembrane pore is driven by a proton gradient. J Mol Biol, 355, 968 - 979.
120. Krantz, B. A., Melnyk, R. A., Zhang, S., Juris, S. J., Lacy, D. B., Wu, Z. et al. 2005b. A phenylalanine clamp catalyzes protein translocation through the anthrax toxin pore. Science, 309, 777 - 781.
121. Kuhn, J. F., Hoerth, P., Hoehn, S. T., Preckel, T., and Tomer, K. B. 2006. Proteomics study of anthrax lethal toxin-treated murine macrophages. Electrophoresis, 27, 1584 - 1597.
122. Kumar, P., Ahuja, N., and Bhatnagar, R. 2002. Anthrax edema toxin requires infl ux of calcium for inducing cyclic AMP toxicity in target cells. Infect Immun, 70, 4997 - 5007.
123. Kuo, S. R., Willingham, M. C., Bour, S. H., Andreas, E. A., Park, S. K., Jackson, C. et al. 2008. Anthrax toxin-induced shock in rats is associated with pulmonary edema and hemorrhage. Microb Pathog, 44, 467 - 472.
124. Labruyere, E., Mock, M., Ladant, D., Michelson, S., Gilles, A. M., Laoide, B. et al. 1990. Characterization of ATP and calmodulin-binding properties of a truncated form of Bacillus anthracis adenylate cyclase. Biochemistry, 29, 4922 - 4928.
125. Labruyere, E., Mock, M., Surewicz, W. K., Mantsch, H. H., Rose, T., Munier, H. et al. 1991. Structural and ligand-binding properties of a truncated form of Bacillus anthracis adenylate cyclase and of a catalytically inactive variant in which glutamine substitutes for lysine-346. Biochemistry, 30, 2619 - 2624.
126. Lacy, D. B., Wigelsworth, D. J., Melnyk, R. A., Harrison, S. C., and Collier, R. J. 2004a. Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formation. Proc Natl Acad Sci U S A, 101: 13147 - 13151.
127. Lacy, D. B., Wigelsworth, D. J., Scobie, H. M., Young, J. A., and Collier, R. J. 2004b. Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: an anthrax toxin receptor. Proc Natl Acad Sci U S A, 101, 6367 - 6372.
128. Larabee, J. L., Degiusti, K., Regens, J. L., and Ballard, J. D. 2008. Bacillus anthracis edema toxin activates nuclear glycogen synthase kinase-3{beta}. Infect Immun, 76, 4895 - 4904.
129. Leppla, S. H. 1982. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc Natl Acad Sci U S A, 79, 3162 - 3166.
130. Leppla, S. H. 1984. Bacillus anthracis calmodulin-dependent adenylate cyclase: chemical and enzymatic properties and interactions with eucaryotic cells. Adv Cyclic Nucleotide Protein Phosphorylation Res, 17, 189 - 198.
131. Leppla, S. H. 1988. Production and purifi cation of anthrax toxin. Methods Enzymol, 165, 103 - 116.
132. Leppla, S. H. 1991. Purifi cation and characterization of adenylyl cyclase from Bacillus anthracis. Methods Enzymol, 195, 153 - 168.
133. Levin, T. C., Wickliffe, K. E., Leppla, S. H., and Moayeri, M. 2008. Heat shock inhibits caspase-1 activity while also preventing its infl ammasome-mediated activation by anthrax lethal toxin. Cell Microbiol, 10, 2434 - 2446.
134. Li, Y., Cui, X., Su, J., Haley, M., Macarthur, H., Sherer, K. et al. 2009. Norepinephrine increases blood pressure but not survival with anthrax lethal toxin in rats. Crit Care Med, 37, 1348 - 1354.
135. Liang, X., Young, J. J., Boone, S. A., Waugh, D. S., and Duesbery, N. S. 2004. Involvement of domain II in toxicity of anthrax lethal factor. J Biol Chem, 279, 52473 - 52478.
136. Lincoln, R. E., Walker, J. S., Klein, F., Rosenwald, A. J., and Jones, W. I. Jr. 1967. Value of fi eld data for extrapolation in anthrax. Fed Proc, 26, 1558 - 1562.
137. Liu, S. and Leppla, S. H. 2003. Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization. J Biol Chem, 278, 5227 - 5234.
138. Liu, S., Leung, H. J., and Leppla, S. H. 2007. Characterization of the interaction between anthrax toxin and its cellular receptors. Cell Microbiol, 9, 977 - 987.
139. Liu, S., Wang, H., Currie, B. M., Molinolo, A., Leung, H. J., Moayeri, M. et al. 2008. Matrix metalloproteinase-activated anthrax lethal toxin demonstrates high potency in targeting tumor vasculature. J Biol Chem, 283, 529 - 540.
140. Lu, Q., Wei, W., Kowalski, P. E., Chang, A. C., and Cohen, S. N. 2004. EST-based genome-wide gene inactivation identifi es ARAP3 as a host protein affecting cellular susceptibility to anthrax toxin. Proc Natl Acad Sci U S A, 101, 17246 - 17251.
141. Mabry, R., Brasky, K., Geiger, R., Carrion, R. Jr. , Hubbard, G. B., Leppla, S. et al. 2006. Detection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassays. Clin Vaccine Immunol, 13, 671 - 677.
142. Maldonado-Arocho, F. J., Fulcher, J. A., Lee, B., and Bradley, K. A. 2006. Anthrax oedema toxin induces anthrax toxin receptor expression in monocyte-derived cells. Mol Microbiol, 61, 324 - 337.
143. Martinon, F. and Tschopp, J. 2007. Infl ammatory caspases and infl ammasomes: master switches of infl ammation. Cell Death Differ, 14, 10 - 22.
144. McAllister, R. D., Singh, Y., Du Bois, W. D., Potter, M., Boehm, T., Meeker, N. D. et al. 2003. Susceptibility to anthrax lethal toxin is controlled by three linked quantitative trait loci. Am J Pathol, 163, 1735 - 1741.
145. Menard, A., Altendorf, K., Breves, D., Mock, M., and Montecucco, C. 1996. The vacuolar ATPase proton pump is required for the cytotoxicity of Bacillus anthracis lethal toxin. FEBS Lett, 386, 161 - 164.
146. Milne, J. C., Furlong, D., Hanna, P. C., Wall, J. S., and Collier, R. J. 1994. Anthrax protective antigen forms oligomers during intoxication of mammalian cells. J Biol Chem, 269, 20607 - 20612.
147. Milne, J. C., Blanke, S. R., Hanna, P. C., and Collier, R. J. 1995. Protective antigen-binding domain of anthrax lethal factor mediates translocation of a heterologous protein fused to its amino-or carboxy-terminus. Mol Microbiol, 15, 661 - 666.
148. Moayeri, M., Haines, D., Young, H. A., and Leppla, S. H. 2003. Bacillus anthracis lethal toxin induces TNF-á-independent hypoxia-mediated toxicity in mice. J Clin Invest, 112, 670 - 682.
149. Moayeri, M., Martinez, N. W., Wiggins, J., Young, H. A., and Leppla, S. H. 2004. Mouse susceptibility to anthrax lethal toxin is infl uenced by genetic factors in addition to those controlling macrophage sensitivity. Infect Immun, 72, 4439 - 4447.
150. Moayeri, M., Webster, J. I., Wiggins, J. F., Leppla, S. H., and Sternberg, E. M. 2005. Endocrine perturbation increases susceptibility of mice to anthrax lethal toxin. Infect Immun, 73, 4238 - 4244.
151. Moayeri, M., Wickliffe, K. E., Wiggins, J. F., and Leppla, S. H. 2006. Oxidized ATP protection against anthrax lethal toxin. Infect Immun, 74, 3707 - 3714.
152. Moayeri, M., Wiggins, J. F., and Leppla, S. H. 2007. Anthrax protective antigen cleavage and clearance from the blood of mice and rats. Infect Immun, 75, 5175 - 5184.
153. Moayeri, M., Crown, D., Dorward, D. W., Gardner, D., Ward, J. M., Li, Y. et al. 2009. The heart is an early target of anthrax lethal toxin in mice: a protective role for neuronal nitric oxide synthase (nNOS). PLoS Pathog, 5, e1000456.
154. Mogridge, J., Cunningham, K., and Collier, R. J. 2002a. Stoichiometry of anthrax toxin complexes. Biochemistry, 41, 1079 - 1082.
155. Mogridge, J., Cunningham, K., Lacy, D. B., Mourez, M., and Collier, R. J. 2002b. The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen. Proc Natl Acad Sci U S A, 99, 7045 - 7048.
156. Muehlbauer, S. M., Evering, T. H., Bonuccelli, G., Squires, R. C., Ashton, A. W., Porcelli, S. A. et al. 2007. Anthrax lethal toxin kills macrophages in a strain-specifi c manner by apoptosis or caspase-1-mediated necrosis. Cell Cycle, 6, 758 - 766.
157. Nanda, A., Carson-Walter, E. B., Seaman, S., Barber, T. D., Stampfl, J., Singh, S. et al. 2004. TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI). Cancer Res, 64, 817 - 820.
158. Nour, A. M., Yeung, Y. G., Santambrogio, L., Boyden, E. D., Stanley, E. R., and Brojatsch, J. 2009. Anthrax lethal toxin triggers the formation of a membrane-associated infl ammasome complex in murine macrophages. Infect Immun, 77, 1262 - 1271.
159. Nye, S. H., Wittenburg, A. L., Evans, D. L., O ' Connor, J. A., Roman, R. J., and Jacob, H. J. 2007. Rat survival to anthrax lethal toxin is likely controlled by a single gene. Pharmacogenomics J, 8, 16 - 22.
160. O ' Brien, J., Friedlander, A., Dreier, T., Ezzell, J., and Leppla, S. 1985. Effects of anthrax toxin components on human neutrophils. Infect Immun, 47, 306 - 310.
161. Paccani, S. R., Tonello, F., Ghittoni, R., Natale, M., Muraro, L., D ' Elios, M. M. et al. 2005. Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling. J Exp Med, 201, 325 - 331.
162. Paccani, S. R., Tonello, F., Patrussi, L., Capitani, N., Simonato, M., Montecucco, C. et al. 2007. Anthrax toxins inhibit immune cell chemotaxis by perturbing chemokine receptor signalling. Cell Microb, 9, 924 - 929.
163. Paddle, B. M., Wong, V. K., and Muller, B. D. 2006. The cytotoxic effect of anthrax lethal toxin on human lung cells in vitro and the protective action of bovine antibodies to PA and LF. J Appl Toxicol, 26, 162 - 168.
164. Panchal, R. G., Halverson, K., Ribot, W., Lane, D., Kenny, T., Abshire, T. G. et al. 2005. Purifi ed Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity. J Biol Chem, 280, 10834 - 10839.
165. Panchal, R. G., Ruthel, G., Brittingham, K. C., Lane, D., Kenny, T. A., Gussio, R. et al. 2007. Chemical genetic screening identifi es critical pathways in anthrax lethal toxin-induced pathogenesis. Chem Biol, 14, 245 - 255.
166. Pandey, J. and Warburton, D. 2004. Knock-on effect of anthrax lethal toxin on macrophages potentiates cytotoxicity to endothelial cells. Microbes Infect, 6, 835 - 843.
167. Pannifer, A. D., Wong, T. Y., Schwarzenbacher, R., Renatus, M., Petosa, C., Bienkowska, J. et al. 2001. Crystal structure of the anthrax lethal factor. Nature, 414, 229 - 233.
168. Park, J. M., Greten, F. R., Li, Z. W., and Karin, M. 2002. Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science, 297, 2048 - 2051.
169. Park, J. M., Greten, F. R., Wong, A., Westrick, R. J., Arthur, J. S., Otsu, K. et al. 2005. Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis - CREB and NF-kappaB as key regulators. Immunity, 23, 319 - 329.
170. Pellizzari, R., Guidi-Rontani, C., Vitale, G., Mock, M., and Montecucco, C. 1999. Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/ IFNgamma-induced release of NO and TNFalpha. FEBS Lett, 462, 199 - 204.
171. Pellizzari, R., Guidi-Rontani, C., Vitale, G., Mock, M., and Montecucco, C. 2000. Lethal factor of Bacillus anthracis cleaves the N-terminus of MAPKKs: analysis of the intracellular consequences in macrophages. Int J Med Microbiol, 290, 421 - 427.
172. Petosa, C., Collier, R. J., Klimpel, K. R., Leppla, S. H., and Liddington, R. C. 1997. Crystal structure of the anthrax toxin protective antigen. Nature, 385, 833 - 838.
173. Petrilli, V., Papin, S., Dostert, C., Mayor, A., Martinon, F., and Tschopp, J. 2007. Activation of the NALP3 infl ammasome is triggered by low intracellular potassium concentration. Cell Death Differ, 14, 1583 - 1589.
174. Pezard, C., Berche, P., and Mock, M. 1991. Contribution of individual toxin components to virulence of Bacillus anthracis. Infect Immun, 59, 3472 - 3477.
175. Pimental, R. A., Christensen, K. A., Krantz, B. A., and Collier, R. J. 2004. Anthrax toxin complexes: heptameric protective antigen can bind lethal factor and edema factor simultaneously. Biochem Biophys Res Commun, 322, 258 - 262.
176. Popov, S. G., Villasmil, R., Bernardi, J., Grene, E., Cardwell, J., Popova, T. et al. 2002a. Effect of Bacillus anthracis lethal toxin on human peripheral blood mononuclear cells. FEBS Lett, 527, 211.
177. Popov, S. G., Villasmil, R., Bernardi, J., Grene, E., Cardwell, J., Wu, A. et al. 2002. Lethal toxin of Bacillus anthracis causes apoptosis of macrophages. Biochem Biophys Res Commun, 293, 349 - 355.
178. Puhar, A. and Montecucco, C. 2007. Where and how do anthrax toxins exit endosomes to intoxicate host cells? Trends Microbiol, 15, 477 - 482.
179. Qa ' Dan, M., Christensen, K. A., Zhang, L., Roberts, T. M., and Collier, R. J. 2005. Membrane insertion by anthrax protective antigen in cultured cells. Mol Cell Biol, 25, 5492 - 5498.
180. Rainey, G. J., Wigelsworth, D. J., Ryan, P. L., Scobie, H. M., Collier, R. J., and Young, J. A. 2005. Receptor-specifi c requirements for anthrax toxin delivery into cells. Proc Natl Acad Sci U S A, 102, 13278 - 13283.
181. Rao, L. V., Ngyuen, M., and Pendurthi, U. R. 2004. Lethal toxin of Bacillus anthracis inhibits tissue factor expression in vascular cells. J Thromb Haemost, 2, 530 - 532.
182. Ratts, R., Zeng, H., Berg, E. A., Blue, C., McComb, M. E., Costello, C. E. et al. 2003. The cytosolic entry of diphtheria toxin catalytic domain requires a host cell cytosolic translocation factor complex. J Cell Biol, 160, 1139 - 1150.
183. Raymond, B., Leduc, D., Ravaux, L., Goffic, R. L., Candela, T., Raymondjean, M. et al. 2007. Edema toxin impairs anthracidal phospholipase A2 expression by alveolar macrophages. PLoS Pathog, 3, e187.
184. Reig, N., Jiang, A., Couture, R., Sutterwala, F. S., Ogura, Y., Flavell, R. A. et al. 2008. Maturation modulates caspase-1-independent responses of dendritic cells to anthrax lethal toxin. Cell Microbiol, 10, 1190 - 1207.
185. Ribot, W. J., Panchal, R. G., Brittingham, K. C., Ruthel, G., Kenny, T. A., Lane, D. et al. 2006. Anthrax lethal toxin impairs innate immune functions of alveolar macrophages and facilitates Bacillus anthracis survival. Infect Immun, 74, 5029 - 5034.
186. Rmali, K. A., Puntis, M. C., and Jiang, W. G. 2005. TEM-8 and tubule formation in endothelial cells, its potential role of its vW/TM domains. Biochem Biophys Res Commun, 334, 231 - 238.
187. Roberts, J. E., Watters, J. W., Ballard, J. D., and Dietrich, W. F. 1998. Ltx1, a mouse locus that infl uences the susceptibility of macrophages to cytolysis caused by intoxication with Bacillus anthracis lethal factor, maps to chromosome 11. Mol Microbiol, 29, 581 - 591.
188. Robertson, D. L. and Leppla, S. H. 1986. Molecular cloning and expression in Escherichia coli of the lethal factor gene of Bacillus anthracis. Gene, 44, 71 - 78.
189. Robertson, D. L., Tippetts, M. T., and Leppla, S. H. 1988. Nucleotide sequence of the Bacillus anthracis edema factor gene ( cya ): a calmodulin-dependent adenylate cyclase. Gene, 73, 363 - 371.
190. Rosovitz, M. J., Schuck, P., Varughese, M., Chopra, A. P., Mehra, V., Singh, Y. et al. 2003. Alanine scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monoclonal antibody. J Biol Chem, 278, 30936 - 30944.
191. Ryan, P. L. and Young, J. A. 2008. Evidence against a human cell-specifi c role for LRP6 in anthrax toxin entry. PLoS ONE, 3, e1817.
192. Salles, I. I., Tucker, A. E., Voth, D. E., and Ballard, J. D. 2003. Toxin-induced resistance in Bacillus anthracis lethal toxin-treated macrophages. Proc Natl Acad Sci U S A, 100, 12426 - 12431.
193. Salles, I. I., Voth, D. E., Ward, S. C., Averette, K. M., Tweten, R. K., Bradley, K. A. et al. 2006. Cytotoxic activity of Bacillus anthracis protective antigen observed in a macrophage cell line overexpressing ANTXR1. Cell Microbiol, 8, 1272 - 1281.
194. Sanchez, A. M., Thomas, D., Gillespie, E. J., Damoiseaux, R., Rodgers, J., Saxe, J. P. et al. 2007. Amiodarone and bepridil inhibit anthrax toxin entry into host cells. Antimicrob Agents Chemother, 51, 2403 - 2411.
195. Santelli, E., Bankston, L. A., Leppla, S. H., and Liddington, R. C. 2004. Crystal structure of a complex between anthrax toxin and its host cell receptor. Nature, 430, 905 - 908.
196. Sapra, R., Gaucher, S. P., Lachmann, J. S., Buffl eben, G. M., Chirica, G. S., Comer, J. E. et al. 2006. Proteomic analyses of murine macrophages treated with Bacillus anthracis lethal toxin. Microb Pathog, 41, 157 - 167.
197. Scobie, H. M., Rainey, G. J., Bradley, K. A., and Young, J. A. 2003. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc Natl Acad Sci U S A, 100, 5170 - 5174.
198. Scobie, H. M., Thomas, D., Marlett, J. M., Destito, G., Wigelsworth, D. J., Collier, R. J. et al. 2005. A soluble receptor decoy protects rats against anthrax lethal toxin challenge. J Infect Dis, 192, 1047 - 1051.
199. Scobie, H. M., Wigelsworth, D. J., Marlett, J. M., Thomas, D., Rainey, G. J., Lacy, D. B. et al. 2006. Anthrax toxin receptor 2-dependent lethal toxin killing in vivo. PLoS Pathog, 2, e111.
200. Sellman, B. R., Mourez, M., and Collier, R. J. 2001. Dominant-negative mutants of a toxin subunit: an approach to therapy of anthrax. Science, 292, 695 - 697.
201. Shen, Y., Lee, Y. S., Soelaiman, S., Bergson, P., Lu, D., Chen, A. et al. 2002. Physiological calcium concentrations regulate calmodulin binding and catalysis of adenylyl cyclase exotoxins. EMBO J, 21, 6721 - 6732.
202. Shen, Y., Zhukovskaya, N. L., Zimmer, M. I., Soelaiman, S., Bergson, P., Wang, C. R. et al. 2004. Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection. Proc Natl Acad Sci U S A, 101, 3242 - 3247.
203. Shen, Y., Zhukovskaya, N. L., Guo, Q., Florian, J., and Tang, W. J. 2005. Calcium-independent calmodulin binding and two-metal-ion catalytic mechanism of anthrax edema factor. EMBO J, 24, 929 - 941.
204. Sherer, K., Li, Y., Cui, X., Li, X., Subramanian, M., Laird, M. W. et al. 2007. Fluid support worsens outcome and negates the benefi t of protective antigen-directed monoclonal antibody in a lethal toxin-infused rat Bacillus anthracis shock model. Crit Care Med, 35, 1560 - 1567.
205. Shin, S., Kim, Y. B., and Hur, G. H. 1999. Involvement of phospholipase A2 activation in anthrax lethal toxin-induced cytotoxicity. Cell Biol Toxicol, 15, 19 - 29.
206. Shin, S., Hur, G. H., Kim, Y. B., Park, K. J., Park, Y. M., and Lee, W. S. 2000. Intracellular calcium antagonist protects cultured peritoneal macrophages against anthrax lethal toxin-induced cytotoxicity. Cell Biol Toxicol, 16, 137 - 144.
207. Singh, Y., Leppla, S. H., Bhatnagar, R., and Friedlander, A. M. 1989. Internalization and processing of Bacillus anthracis lethal toxin by toxin-sensitive and-resistant cells. J Biol Chem, 264, 11099 - 11102.
208. Singh, Y., Klimpel, K. R., Goel, S., Swain, P. K., and Leppla, S. H. 1999. Oligomerization of anthrax toxin protective antigen and binding of lethal factor during endocytic uptake into mammalian cells. Infect Immun, 67, 1853 - 1859.
209. Sirard, J. C., Mock, M., and Fouet, A. 1994. The three Bacillus anthracis toxin genes are coordinately regulated by bicarbonate and temperature. J Bacteriol, 176, 5188 - 5192.
210. Smith, H. 2002. Discovery of the anthrax toxin: the beginning of studies of virulence determinants regulated in vivo. Int J Med Microbiol, 291, 411 - 417.
211. Smith, H. and Keppie, J. 1954. Observations on experimental anthrax: demonstration of a specifi c lethal factor produced in vivo by Bacillus anthracis. Nature, 173, 869 - 870.
212. Smith, H. and Stanley, J. L. 1962. Purifi cation of the third factor of anthrax toxin. J Gen Microbiol, 29, 517 - 521.
213. Smith, H., Keppie, J., and Stanley, J. L. 1955. The chemical basis of the virulence of Bacillus anthracis. V: The specifi c toxin produced by B. anthracis in vivo. Br J Exp Pathol, 36, 460 - 472.
214. Squires, R. C., Muehlbauer, S. M., and Brojatsch, J. 2007. Proteasomes control caspase-1 activation in anthrax lethal toxin-mediated cell killing. J Biol Chem, 282, 34260 - 34267.
215. Stanley, J. L. and Smith, H. 1961. Purifi cation of factor I and recognition of a third factor of anthrax toxin. J Gen Microbiol, 26, 49 - 66.
216. Stanley, J. L., Sargeant, K., and Smith, H. 1960. Purifi cation of factors I and II of the anthrax toxin produced in vivo. J Gen Microbiol, 22, 206 - 218.
217. Steele, A. D., Warfel, J. M., and D ' Agnillo, F. 2005. Anthrax lethal toxin enhances cytokine-induced VCAM-1 expression on human endothelial cells. Biochem Biophys Res Commun, 337, 1249 - 1256.
218. Stepanov, A. V., Marinin, L. I., Pomerantsev, A. P., and Staritsin, N. A. 1996. Development of novel vaccines against anthrax in man. J Biotechnol, 44, 155 - 160.
219. Sun, J., Lang, A. E., Aktories, K., and Collier, R. J. 2008. Phenylalanine-427 of anthrax protective antigen functions in both pore formation and protein translocation. Proc Natl Acad Sci U S A, 105, 4346 - 4351.
220. Tamayo, A. G., Bharti, A., Trujillo, C., Harrison, R., and Murphy, J. R. 2008. COPI coatomer complex proteins facilitate the translocation of anthrax lethal factor across vesicular membranes in vitro. Proc Natl Acad Sci U S A, 105, 5254 - 5259.
221. Tang, G. and Leppla, S. H. 1999. Proteasome activity is required for anthrax lethal toxin to kill macrophages. Infect Immun, 67, 3055 - 3060.
222. Tessier, J., Green, C., Padgett, D., Zhao, W., Schwartz, L., Hughes, M. et al. 2007. Contributions of histamine, prostanoids, and neurokinins to edema elicited by edema toxin from Bacillus anthracis. Infect Immun, 75, 1895 - 1903.
223. Tournier, J. N., Quesnel-Hellmann, A., Mathieu, J., Montecucco, C., Tang, W. J., Mock, M. et al. 2005. Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells. J Immunol, 174, 4934 - 4941.
224. Triantafi lou, M., Uddin, A., Maher, S., Charalambous, N., Hamm, T. S., Alsumaiti, A. et al. 2007. Anthrax toxin evades Toll-like receptor recognition, whereas its cell wall components trigger activation via TLR2/6 heterodimers. C ell Microbiol, 9, 2880 - 2892.
225. Tschopp, J., Martinon, F., and Burns, K. 2003. NALPs: a novel protein family involved in infl ammation. Nat Rev Mol Cell Biol, 4, 95 - 104.
226. Tucker, A. E., Salles, I. I., Voth, D. E., Ortiz-Leduc, W., Wang, H., Dozmorov, I. et al. 2003. Decreased glycogen synthase kinase 3-beta levels and related physiological changes in Bacillus anthracis lethal toxin-treated macrophages. Cell Microbiol, 5, 523 - 532.
227. Ulmer, T. S., Soelaiman, S., Li, S., Klee, C. B., Tang, W. J., and Bax, A. 2003. Calcium dependence of the interaction between calmodulin and anthrax edema factor. J Biol Chem, 278, 29261 - 29266.
228. Vande Velde, C., Cizeau, J., Dubik, D., Alimonti, J., Brown, T., Israels, S. et al. 2000. BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol, 20, 5454 - 5468.
229. Varshavsky, A. 1997. The N-end rule pathway of protein degradation. Genes Cells, 2, 13 - 28.
230. Vasconcelos, D., Barnewall, R., Babin, M., Hunt, R., Estep, J., Nielsen, C. et al. 2003. Pathology of inhalation anthrax in cynomolgus monkeys ( Macaca fascicularis ). Lab Invest, 83, 1201 - 1209.
231. Verma, A., Wagner, L., Stibitz, S., Nguyen, N., Guerengomba, F., and Burns, D. L. 2008. Role of the N-terminal amino acid of Bacillus anthracis lethal factor in lethal toxin cytotoxicity and its effect on the lethal toxin neutralization assay. Clin Vaccine Immunol, 15, 1737 - 1741.
232. Vitale, G., Pellizzari, R., Recchi, C., Napolitani, G., Mock, M., and Montecucco, C. 1998. Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem Biophys Res Commun, 248, 706 - 711.
233. Vitale, G., Bernardi, L., Napolitani, G., Mock, M., and Montecucco, C. 2000. Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor. Biochem J, 352, 739 - 745. Vodkin, M. H. and Leppla, S. H. 1983. Cloning of the protective antigen gene of Bacillus anthracis. Cell, 34, 693 - 697.
234. Voth, D. E., Hamm, E. E., Nguyen, L. G., Tucker, A. E., Salles, I. I., Ortiz-Leduc, W. et al. 2005. Bacillus anthracis oedema toxin as a cause of tissue necrosis and cell type-specifi c cytotoxicity. Cell Microbiol, 7, 1139 - 1149.
235. Wade, B. H., Wright, G. G., Hewlett, E. L., Leppla, S. H., and Mandell, G. L. 1985. Anthrax toxin components stimulate chemotaxis of human polymorphonuclear neutrophils. Proc Soc Exp Biol Med, 179, 159 - 162.
236. Warfel, J. M. and D ' Agnillo, F. 2008. Anthrax lethal toxin enhances TNF-induced endothelial VCAM-1 expression via an IFN regulatory factor-1-dependent mechanism. J Immunol, 180, 7516 - 7524.
237. Warfel, J. M., Steele, A. D., and D ' Agnillo, F. 2005. Anthrax lethal toxin induces endothelial barrier dysfunction. Am J Pathol, 166, 1871 - 1881.
238. Watson, L. E., Kuo, S. R., Katki, K., Dang, T., Park, S. K., Dostal, D. E. et al. 2007. Anthrax toxins induce shock in rats by depressed cardiac ventricular function. PLoS ONE, 2, e466
239. Watson, L. E., Mock, J., Lal, H., Lu, G., Bourdeau, R. W., Tang, W. J. et al. 2007b. Lethal and edema toxins of anthrax induce distinct hemodynamic dysfunction. Front Biosci, 12, 4670 - 4675.
240. Watters, J. W., Dewar, K., Lehoczky, J., Boyartchuk, V., and Dietrich, W. F. 2001. Kif1C, a kinesin-like motor protein, mediates mouse macrophage resistance to anthrax lethal factor. Curr Biol, 11, 1503 - 1511.
241. Webster, J. I. and Sternberg, E. M. 2005. Anthrax lethal toxin represses glucocorticoid receptor (GR) transactivation by inhibiting GR-DNA binding in vivo. Mol Cell Endocrinol, 241, 21 - 31.
242. Webster, J. I., Tonelli, L. H., Moayeri, M., Simons, S. S. Jr. , Leppla, S. H., and Sternberg, E. M. 2003. Anthrax lethal factor represses glucocorticoid and progesterone receptor activity. Proc Natl Acad Sci U S A, 100, 5706 - 5711.
243. Wei, W., Lu, Q., Chaudry, G. J., Leppla, S. H., and Cohen, S. N. 2006. The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin. Cell, 124, 1141 - 1154.
244. Welkos, S., Little, S., Friedlander, A., Fritz, D., and Fellows, P. 2001. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores. Microbiology, 147, 1677 - 1685.
245. Welkos, S., Friedlander, A., Weeks, S., Little, S., and Mendelson, I. 2002. In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody. J Med Microbiol, 51, 821 - 831.
246. Welkos, S. L., Keener, T. J., and Gibbs, P. H. 1986. Differences in susceptibility of inbred mice to Bacillus anthracis. Infect Immun, 51, 795 - 800.
247. Welkos, S. L., Lowe, J. R., Eden-McCutchan, F., Vodkin, M., Leppla, S. H., and Schmidt, J. J. 1988. Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracis. Gene, 69, 287 - 300.
248. Welkos, S. L., Trotter, R. W., Becker, D. M., and Nelson, G. O. 1989. Resistance to the Sterne strain of B. anthracis: phagocytic cell responses of resistant and susceptible mice. Microb Pathog, 7, 15 - 35.
249. Werner, E., Kowalczyk, A. P., and Faundez, V. 2006. Anthrax receptor 1/tumor endothelium marker 8 mediates cell spreading by coupling extracellular ligands to the actin cytoskeleton. J Biol Chem, 281, 23227 - 23236.
250. Wesche, J., Elliott, J. L., Falnes, P. O., Olsnes, S., and Collier, R. J. 1998. Characterization of membrane translocation by anthrax protective antigen. Biochemistry, 37, 15737 - 15746.
251. Wickliffe, K. E., Leppla, S. H., and Moayeri, M. 2008a. Killing of macrophages by anthrax lethal toxin: involvement of the N-end rule pathway. Cell Microbiol, 10, 1352 - 1362.
252. Wickliffe, K. E., Leppla, S. H., and Moayeri, M. 2008b. Anthrax lethal toxin-induced infl ammasome formation and caspase-1 activation are late events dependent on ion fl uxes and the proteasome. Cell Microbiol, 10, 332 - 343.
253. Wigelsworth, D. J., Krantz, B. A., Christensen, K. A., Lacy, D. B., Juris, S. J., and Collier, R. J. 2004. Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen. J Biol Chem, 279, 23349 - 23356.
254. Wright, G. G. and Mandell, G. L. 1986. Anthrax toxin blocks priming of neutrophils by lipopolysaccharide and by muramyl dipeptide. J Exp Med, 164, 1700 - 1709.
255. Xu, L., Fang, H., and Frucht, D. M. 2008. Anthrax lethal toxin increases superoxide production in murine neutrophils via differential effects on MAPK signaling pathways. J Immunol, 180, 4139 - 4147.
256. Yan, M. and Collier, R. J. 2003. Characterization of dominant-negative forms of anthrax protective antigen. Mol Med, 9, 46 - 51.
257. Young, J. A. and Collier, R. J. 2007. Anthrax toxin: receptor-binding, internalization, pore formation, and translocation. A nnu Rev Biochem, 76, 243 - 265.
258. Young, J. J., Bromberg-White, J. L., Zylstra, C., Church, J. T., Boguslawski, E., Resau, J. H. et al. 2007. LRP5 and LRP6 are not required for protective antigen-mediated internalization or lethality of anthrax lethal toxin. PLoS Pathog, 3, e27.
259. Yu, H. B. and Finlay, B. B. 2008. The caspase-1 infl ammasome: a pilot of innate immune responses. Cell Host Microbe, 4, 198 - 208.
260. Zaucha, G. M., Pitt, M. L., Estep, J., Ivins, B. E., and Friedlander, A. M. 1998. The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation. Arch Pathol Lab Med, 122, 982 - 992.
261. Zhang, S., Cunningham, K., and Collier, R. J. 2004a. Anthrax protective antigen: effi ciency of translocation is independent of the number of ligands bound to the prepore. Biochemistry, 43, 6339 - 6343.
262. Zhang, S., Finkelstein, A., and Collier, R. J. 2004b. Evidence that translocation of anthrax toxin ' s lethal factor is initiated by entry of its N terminus into the protective antigen channel. Proc Natl Acad Sci U S A, 101, 16756 - 16761.